Vodič za dijagnostikovanje i lečenje raka grlića materice - Institut za ...

36. Barron, BA, Cahill MV, Richart RM: A statistical model of the natural history of
cervical neoplastic disease. The duration of carcinoma in situ. Gynecol Oncol, 1978;
6: 196-205
37. Massad LS, Halperin CJ, Bitterman P. Correlation between colposcopically directed
biopsy and cervical loop excision. Gynecol Oncol, 1996; 60: 400-3
38. Mesher D, Szarewski A, Cadman L et al. Long-term follow-up of cervical disease in
women screened by cytology and HPV testing: results from the HART study. Br. J.
Cancer 2010;102:1405-10
39. Martin-Hirsch PP, Paraskevaidis E, Bryant A, Dickinson HO, Keep SL. Surgery for
cervical intraepithelial neoplasia. Cochrane Database Syst Rev 2010;6:CD001318.
40. Jordan J, Martin-Hirsch P, Arbyn M, Schenk U, Baldauf J-J, Da Silva D, Antilla A,
Nieminen P, Prendiville W. European guidelines for clinical management of abnormal
cervical cytology. Part 2. Cytopathology, 2009; 20: 5-16
41. Kyrgiou M. Kolliopulous G, Marin-Hirsch P et al. Obstetric outcomes after
conservative treatment for intraepithelial or early invasive cervical lesions: a
systematic review and meta-analysis of the literature. Lancet, 2006; 367: 489-98
42. Cox JT. Management of women with cervical cancer precursor lesions. Obstet
Gynecol Clin North Am, 2002; 29: 787-816
43. Ulrich D, Tamussino K ,Petru E, Haas J, Reich. O. Conization of the Uterine Cervix:
Does the Level of Gynecologist's Training Predict Margin Status? Int J Gynecol
Pathol 2012; 31:382-386
44. Flanelly G, Bolger B, Fawzi H, De Lopes AB, Monaghan JM. Follow-up after LLETZ:
could schedule be modified according to risk of recurrence? BJOG, 2001; 108: 1025-
30
45. W.P Soutter, A de Barros Lopes, A Fletcher et al. Invasive cervical cancer after
conservative therapy for cervical intraepithelial neoplasia. Lancet, 1997; 349:978–
980
46. Paraskevaidis E, Arbyn M, Sotiriadis E, Diakommanolis E, Martin-Hirsch P,
Koliopulos G, Makrydimas E, Tofoski J, Roukos DH. The role of HPV DNA testing in
the follow-up period after treatment for CIN: a systematic review of the
literatureCancer Treatment Reviews, 2004; 30: 205-211
47. AbrynM. Paraskevaides E, martin-Hirsch P, Prendiville W, Dillner J. Cilinical utiity of
HPV DNA detection: triage of minor cervical lesions, follow-up of women treated for
high-grade CIN. An update of pooled evidence. Gynecol Oncol, 2005; 99 (Suppl 3):
7-11
48. Tavassoéli, F.A., Devilee, P. IARC WHO Classification of Tumours, Pathology and
Genetics Tumours of the Breast and Female Genital Organs, Vol 4, 3 rd edition, IARC
publications, Lyon, 2003.
49. Kurman RJ, Hedrick-Ellenson L, Ronnett BM eds. Blaustein’s Pathology of the
Female Genital Tract, 6th edition. Springer, 2011
50. Barakat RR, Bevers MW, gerhenson DM, Hoskins WJ. Handbook of Gynecologic
Oncology, 2nd ed. London, Martin Dunitz Publishrs Ltd, 2002
51. FIGO Committee on Gynecologic Oncology. Revised FIGO staging for carcinoma of
the vulva, cervix, and endometrium. International Journal of Gynecology and
Obstetrics,2009;105: 103–104
52. Scottish Intercollegiate Guidelines Network. Management of cervical cancer. A
national clinical guideline, SIGN, 2008
53. Bipat S, Glas AS, van der Velden J, Zwinderman AH, Bossuyt PM, Stoker J.
Computed tomography and magnetic resonance imaging in staging of uterine
cervical carcinoma: a systematic review. Gynecol Oncol. 2003; 91:59-66
54. Narayan K, Hicks RJ, Jobling T, Bernshaw D, McKenzie AF. A comparison of MRI
and PE T scanning in surgically staged loco-regionally advanced cervical cancer:
potential impact on treatment. Int J Gynaecol Cancer 2001;11:263-71.
70